Does PEMBROLIZUMAB Cause Psoriasis? 261 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 261 reports of Psoriasis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.3% of all adverse event reports for PEMBROLIZUMAB.
261
Reports of Psoriasis with PEMBROLIZUMAB
0.3%
of all PEMBROLIZUMAB reports
7
Deaths
66
Hospitalizations
How Dangerous Is Psoriasis From PEMBROLIZUMAB?
Of the 261 reports, 7 (2.7%) resulted in death, 66 (25.3%) required hospitalization, and 5 (1.9%) were considered life-threatening.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 261 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which PEMBROLIZUMAB Alternatives Have Lower Psoriasis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G